| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |